Global Palonosetron Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).
LPI (LP Information)' newest research report, the “Palonosetron Industry Forecast” looks at past sales and reviews total world Palonosetron sales in 2022, providing a comprehensive analysis by region and market sector of projected Palonosetron sales for 2023 through 2029. With Palonosetron sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Palonosetron industry.
This Insight Report provides a comprehensive analysis of the global Palonosetron landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Palonosetron portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Palonosetron market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Palonosetron and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Palonosetron.
The global Palonosetron market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Palonosetron is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Palonosetron is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Palonosetron is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Palonosetron players cover Helsinn Therapeutics, Teva, Dr. Reddys Laboratories, Cipla, Pfizer, Sandoz, Aurobindo, Sagent Pharmaceuticals and Fresenius Kabi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Palonosetron market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Palonosetron market?
What factors are driving Palonosetron market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Palonosetron market opportunities vary by end market size?
How does Palonosetron break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).
LPI (LP Information)' newest research report, the “Palonosetron Industry Forecast” looks at past sales and reviews total world Palonosetron sales in 2022, providing a comprehensive analysis by region and market sector of projected Palonosetron sales for 2023 through 2029. With Palonosetron sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Palonosetron industry.
This Insight Report provides a comprehensive analysis of the global Palonosetron landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Palonosetron portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Palonosetron market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Palonosetron and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Palonosetron.
The global Palonosetron market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Palonosetron is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Palonosetron is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Palonosetron is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Palonosetron players cover Helsinn Therapeutics, Teva, Dr. Reddys Laboratories, Cipla, Pfizer, Sandoz, Aurobindo, Sagent Pharmaceuticals and Fresenius Kabi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Palonosetron market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Injection 0.25 mg/5 mL
- Injection 20 mcg/kg (max 1.5 mg)
- Adults
- Children
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Helsinn Therapeutics
- Teva
- Dr. Reddys Laboratories
- Cipla
- Pfizer
- Sandoz
- Aurobindo
- Sagent Pharmaceuticals
- Fresenius Kabi
- Qilu Pharmaceutical
- Jiangsu Aosaikang Pharmaceutical
- Sichuan Hairong Pharmaceutical
- Exela Pharma
What is the 10-year outlook for the global Palonosetron market?
What factors are driving Palonosetron market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Palonosetron market opportunities vary by end market size?
How does Palonosetron break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Palonosetron Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Palonosetron by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Palonosetron by Country/Region, 2018, 2022 & 2029
2.2 Palonosetron Segment by Type
2.2.1 Injection 0.25 mg/5 mL
2.2.2 Injection 20 mcg/kg (max 1.5 mg)
2.3 Palonosetron Sales by Type
2.3.1 Global Palonosetron Sales Market Share by Type (2018-2023)
2.3.2 Global Palonosetron Revenue and Market Share by Type (2018-2023)
2.3.3 Global Palonosetron Sale Price by Type (2018-2023)
2.4 Palonosetron Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Palonosetron Sales by Application
2.5.1 Global Palonosetron Sale Market Share by Application (2018-2023)
2.5.2 Global Palonosetron Revenue and Market Share by Application (2018-2023)
2.5.3 Global Palonosetron Sale Price by Application (2018-2023)
3 GLOBAL PALONOSETRON BY COMPANY
3.1 Global Palonosetron Breakdown Data by Company
3.1.1 Global Palonosetron Annual Sales by Company (2018-2023)
3.1.2 Global Palonosetron Sales Market Share by Company (2018-2023)
3.2 Global Palonosetron Annual Revenue by Company (2018-2023)
3.2.1 Global Palonosetron Revenue by Company (2018-2023)
3.2.2 Global Palonosetron Revenue Market Share by Company (2018-2023)
3.3 Global Palonosetron Sale Price by Company
3.4 Key Manufacturers Palonosetron Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Palonosetron Product Location Distribution
3.4.2 Players Palonosetron Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PALONOSETRON BY GEOGRAPHIC REGION
4.1 World Historic Palonosetron Market Size by Geographic Region (2018-2023)
4.1.1 Global Palonosetron Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Palonosetron Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Palonosetron Market Size by Country/Region (2018-2023)
4.2.1 Global Palonosetron Annual Sales by Country/Region (2018-2023)
4.2.2 Global Palonosetron Annual Revenue by Country/Region (2018-2023)
4.3 Americas Palonosetron Sales Growth
4.4 APAC Palonosetron Sales Growth
4.5 Europe Palonosetron Sales Growth
4.6 Middle East & Africa Palonosetron Sales Growth
5 AMERICAS
5.1 Americas Palonosetron Sales by Country
5.1.1 Americas Palonosetron Sales by Country (2018-2023)
5.1.2 Americas Palonosetron Revenue by Country (2018-2023)
5.2 Americas Palonosetron Sales by Type
5.3 Americas Palonosetron Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Palonosetron Sales by Region
6.1.1 APAC Palonosetron Sales by Region (2018-2023)
6.1.2 APAC Palonosetron Revenue by Region (2018-2023)
6.2 APAC Palonosetron Sales by Type
6.3 APAC Palonosetron Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Palonosetron by Country
7.1.1 Europe Palonosetron Sales by Country (2018-2023)
7.1.2 Europe Palonosetron Revenue by Country (2018-2023)
7.2 Europe Palonosetron Sales by Type
7.3 Europe Palonosetron Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Palonosetron by Country
8.1.1 Middle East & Africa Palonosetron Sales by Country (2018-2023)
8.1.2 Middle East & Africa Palonosetron Revenue by Country (2018-2023)
8.2 Middle East & Africa Palonosetron Sales by Type
8.3 Middle East & Africa Palonosetron Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Palonosetron
10.3 Manufacturing Process Analysis of Palonosetron
10.4 Industry Chain Structure of Palonosetron
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Palonosetron Distributors
11.3 Palonosetron Customer
12 WORLD FORECAST REVIEW FOR PALONOSETRON BY GEOGRAPHIC REGION
12.1 Global Palonosetron Market Size Forecast by Region
12.1.1 Global Palonosetron Forecast by Region (2024-2029)
12.1.2 Global Palonosetron Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Palonosetron Forecast by Type
12.7 Global Palonosetron Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Helsinn Therapeutics
13.1.1 Helsinn Therapeutics Company Information
13.1.2 Helsinn Therapeutics Palonosetron Product Portfolios and Specifications
13.1.3 Helsinn Therapeutics Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Helsinn Therapeutics Main Business Overview
13.1.5 Helsinn Therapeutics Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Palonosetron Product Portfolios and Specifications
13.2.3 Teva Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Dr. Reddys Laboratories
13.3.1 Dr. Reddys Laboratories Company Information
13.3.2 Dr. Reddys Laboratories Palonosetron Product Portfolios and Specifications
13.3.3 Dr. Reddys Laboratories Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Dr. Reddys Laboratories Main Business Overview
13.3.5 Dr. Reddys Laboratories Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Palonosetron Product Portfolios and Specifications
13.4.3 Cipla Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Palonosetron Product Portfolios and Specifications
13.5.3 Pfizer Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Sandoz
13.6.1 Sandoz Company Information
13.6.2 Sandoz Palonosetron Product Portfolios and Specifications
13.6.3 Sandoz Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sandoz Main Business Overview
13.6.5 Sandoz Latest Developments
13.7 Aurobindo
13.7.1 Aurobindo Company Information
13.7.2 Aurobindo Palonosetron Product Portfolios and Specifications
13.7.3 Aurobindo Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Aurobindo Main Business Overview
13.7.5 Aurobindo Latest Developments
13.8 Sagent Pharmaceuticals
13.8.1 Sagent Pharmaceuticals Company Information
13.8.2 Sagent Pharmaceuticals Palonosetron Product Portfolios and Specifications
13.8.3 Sagent Pharmaceuticals Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sagent Pharmaceuticals Main Business Overview
13.8.5 Sagent Pharmaceuticals Latest Developments
13.9 Fresenius Kabi
13.9.1 Fresenius Kabi Company Information
13.9.2 Fresenius Kabi Palonosetron Product Portfolios and Specifications
13.9.3 Fresenius Kabi Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Fresenius Kabi Main Business Overview
13.9.5 Fresenius Kabi Latest Developments
13.10 Qilu Pharmaceutical
13.10.1 Qilu Pharmaceutical Company Information
13.10.2 Qilu Pharmaceutical Palonosetron Product Portfolios and Specifications
13.10.3 Qilu Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Qilu Pharmaceutical Main Business Overview
13.10.5 Qilu Pharmaceutical Latest Developments
13.11 Jiangsu Aosaikang Pharmaceutical
13.11.1 Jiangsu Aosaikang Pharmaceutical Company Information
13.11.2 Jiangsu Aosaikang Pharmaceutical Palonosetron Product Portfolios and Specifications
13.11.3 Jiangsu Aosaikang Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Jiangsu Aosaikang Pharmaceutical Main Business Overview
13.11.5 Jiangsu Aosaikang Pharmaceutical Latest Developments
13.12 Sichuan Hairong Pharmaceutical
13.12.1 Sichuan Hairong Pharmaceutical Company Information
13.12.2 Sichuan Hairong Pharmaceutical Palonosetron Product Portfolios and Specifications
13.12.3 Sichuan Hairong Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Sichuan Hairong Pharmaceutical Main Business Overview
13.12.5 Sichuan Hairong Pharmaceutical Latest Developments
13.13 Exela Pharma
13.13.1 Exela Pharma Company Information
13.13.2 Exela Pharma Palonosetron Product Portfolios and Specifications
13.13.3 Exela Pharma Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Exela Pharma Main Business Overview
13.13.5 Exela Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Palonosetron Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Palonosetron by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Palonosetron by Country/Region, 2018, 2022 & 2029
2.2 Palonosetron Segment by Type
2.2.1 Injection 0.25 mg/5 mL
2.2.2 Injection 20 mcg/kg (max 1.5 mg)
2.3 Palonosetron Sales by Type
2.3.1 Global Palonosetron Sales Market Share by Type (2018-2023)
2.3.2 Global Palonosetron Revenue and Market Share by Type (2018-2023)
2.3.3 Global Palonosetron Sale Price by Type (2018-2023)
2.4 Palonosetron Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Palonosetron Sales by Application
2.5.1 Global Palonosetron Sale Market Share by Application (2018-2023)
2.5.2 Global Palonosetron Revenue and Market Share by Application (2018-2023)
2.5.3 Global Palonosetron Sale Price by Application (2018-2023)
3 GLOBAL PALONOSETRON BY COMPANY
3.1 Global Palonosetron Breakdown Data by Company
3.1.1 Global Palonosetron Annual Sales by Company (2018-2023)
3.1.2 Global Palonosetron Sales Market Share by Company (2018-2023)
3.2 Global Palonosetron Annual Revenue by Company (2018-2023)
3.2.1 Global Palonosetron Revenue by Company (2018-2023)
3.2.2 Global Palonosetron Revenue Market Share by Company (2018-2023)
3.3 Global Palonosetron Sale Price by Company
3.4 Key Manufacturers Palonosetron Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Palonosetron Product Location Distribution
3.4.2 Players Palonosetron Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PALONOSETRON BY GEOGRAPHIC REGION
4.1 World Historic Palonosetron Market Size by Geographic Region (2018-2023)
4.1.1 Global Palonosetron Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Palonosetron Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Palonosetron Market Size by Country/Region (2018-2023)
4.2.1 Global Palonosetron Annual Sales by Country/Region (2018-2023)
4.2.2 Global Palonosetron Annual Revenue by Country/Region (2018-2023)
4.3 Americas Palonosetron Sales Growth
4.4 APAC Palonosetron Sales Growth
4.5 Europe Palonosetron Sales Growth
4.6 Middle East & Africa Palonosetron Sales Growth
5 AMERICAS
5.1 Americas Palonosetron Sales by Country
5.1.1 Americas Palonosetron Sales by Country (2018-2023)
5.1.2 Americas Palonosetron Revenue by Country (2018-2023)
5.2 Americas Palonosetron Sales by Type
5.3 Americas Palonosetron Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Palonosetron Sales by Region
6.1.1 APAC Palonosetron Sales by Region (2018-2023)
6.1.2 APAC Palonosetron Revenue by Region (2018-2023)
6.2 APAC Palonosetron Sales by Type
6.3 APAC Palonosetron Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Palonosetron by Country
7.1.1 Europe Palonosetron Sales by Country (2018-2023)
7.1.2 Europe Palonosetron Revenue by Country (2018-2023)
7.2 Europe Palonosetron Sales by Type
7.3 Europe Palonosetron Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Palonosetron by Country
8.1.1 Middle East & Africa Palonosetron Sales by Country (2018-2023)
8.1.2 Middle East & Africa Palonosetron Revenue by Country (2018-2023)
8.2 Middle East & Africa Palonosetron Sales by Type
8.3 Middle East & Africa Palonosetron Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Palonosetron
10.3 Manufacturing Process Analysis of Palonosetron
10.4 Industry Chain Structure of Palonosetron
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Palonosetron Distributors
11.3 Palonosetron Customer
12 WORLD FORECAST REVIEW FOR PALONOSETRON BY GEOGRAPHIC REGION
12.1 Global Palonosetron Market Size Forecast by Region
12.1.1 Global Palonosetron Forecast by Region (2024-2029)
12.1.2 Global Palonosetron Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Palonosetron Forecast by Type
12.7 Global Palonosetron Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Helsinn Therapeutics
13.1.1 Helsinn Therapeutics Company Information
13.1.2 Helsinn Therapeutics Palonosetron Product Portfolios and Specifications
13.1.3 Helsinn Therapeutics Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Helsinn Therapeutics Main Business Overview
13.1.5 Helsinn Therapeutics Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Palonosetron Product Portfolios and Specifications
13.2.3 Teva Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Dr. Reddys Laboratories
13.3.1 Dr. Reddys Laboratories Company Information
13.3.2 Dr. Reddys Laboratories Palonosetron Product Portfolios and Specifications
13.3.3 Dr. Reddys Laboratories Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Dr. Reddys Laboratories Main Business Overview
13.3.5 Dr. Reddys Laboratories Latest Developments
13.4 Cipla
13.4.1 Cipla Company Information
13.4.2 Cipla Palonosetron Product Portfolios and Specifications
13.4.3 Cipla Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cipla Main Business Overview
13.4.5 Cipla Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Palonosetron Product Portfolios and Specifications
13.5.3 Pfizer Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Sandoz
13.6.1 Sandoz Company Information
13.6.2 Sandoz Palonosetron Product Portfolios and Specifications
13.6.3 Sandoz Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sandoz Main Business Overview
13.6.5 Sandoz Latest Developments
13.7 Aurobindo
13.7.1 Aurobindo Company Information
13.7.2 Aurobindo Palonosetron Product Portfolios and Specifications
13.7.3 Aurobindo Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Aurobindo Main Business Overview
13.7.5 Aurobindo Latest Developments
13.8 Sagent Pharmaceuticals
13.8.1 Sagent Pharmaceuticals Company Information
13.8.2 Sagent Pharmaceuticals Palonosetron Product Portfolios and Specifications
13.8.3 Sagent Pharmaceuticals Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sagent Pharmaceuticals Main Business Overview
13.8.5 Sagent Pharmaceuticals Latest Developments
13.9 Fresenius Kabi
13.9.1 Fresenius Kabi Company Information
13.9.2 Fresenius Kabi Palonosetron Product Portfolios and Specifications
13.9.3 Fresenius Kabi Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Fresenius Kabi Main Business Overview
13.9.5 Fresenius Kabi Latest Developments
13.10 Qilu Pharmaceutical
13.10.1 Qilu Pharmaceutical Company Information
13.10.2 Qilu Pharmaceutical Palonosetron Product Portfolios and Specifications
13.10.3 Qilu Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Qilu Pharmaceutical Main Business Overview
13.10.5 Qilu Pharmaceutical Latest Developments
13.11 Jiangsu Aosaikang Pharmaceutical
13.11.1 Jiangsu Aosaikang Pharmaceutical Company Information
13.11.2 Jiangsu Aosaikang Pharmaceutical Palonosetron Product Portfolios and Specifications
13.11.3 Jiangsu Aosaikang Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Jiangsu Aosaikang Pharmaceutical Main Business Overview
13.11.5 Jiangsu Aosaikang Pharmaceutical Latest Developments
13.12 Sichuan Hairong Pharmaceutical
13.12.1 Sichuan Hairong Pharmaceutical Company Information
13.12.2 Sichuan Hairong Pharmaceutical Palonosetron Product Portfolios and Specifications
13.12.3 Sichuan Hairong Pharmaceutical Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Sichuan Hairong Pharmaceutical Main Business Overview
13.12.5 Sichuan Hairong Pharmaceutical Latest Developments
13.13 Exela Pharma
13.13.1 Exela Pharma Company Information
13.13.2 Exela Pharma Palonosetron Product Portfolios and Specifications
13.13.3 Exela Pharma Palonosetron Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Exela Pharma Main Business Overview
13.13.5 Exela Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Palonosetron Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Palonosetron Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Injection 0.25 mg/5 mL
Table 4. Major Players of Injection 20 mcg/kg (max 1.5 mg)
Table 5. Global Palonosetron Sales by Type (2018-2023) & (K Units)
Table 6. Global Palonosetron Sales Market Share by Type (2018-2023)
Table 7. Global Palonosetron Revenue by Type (2018-2023) & ($ million)
Table 8. Global Palonosetron Revenue Market Share by Type (2018-2023)
Table 9. Global Palonosetron Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Palonosetron Sales by Application (2018-2023) & (K Units)
Table 11. Global Palonosetron Sales Market Share by Application (2018-2023)
Table 12. Global Palonosetron Revenue by Application (2018-2023)
Table 13. Global Palonosetron Revenue Market Share by Application (2018-2023)
Table 14. Global Palonosetron Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Palonosetron Sales by Company (2018-2023) & (K Units)
Table 16. Global Palonosetron Sales Market Share by Company (2018-2023)
Table 17. Global Palonosetron Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Palonosetron Revenue Market Share by Company (2018-2023)
Table 19. Global Palonosetron Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Palonosetron Producing Area Distribution and Sales Area
Table 21. Players Palonosetron Products Offered
Table 22. Palonosetron Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Palonosetron Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Palonosetron Sales Market Share Geographic Region (2018-2023)
Table 27. Global Palonosetron Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Palonosetron Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Palonosetron Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Palonosetron Sales Market Share by Country/Region (2018-2023)
Table 31. Global Palonosetron Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Palonosetron Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Palonosetron Sales by Country (2018-2023) & (K Units)
Table 34. Americas Palonosetron Sales Market Share by Country (2018-2023)
Table 35. Americas Palonosetron Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Palonosetron Revenue Market Share by Country (2018-2023)
Table 37. Americas Palonosetron Sales by Type (2018-2023) & (K Units)
Table 38. Americas Palonosetron Sales by Application (2018-2023) & (K Units)
Table 39. APAC Palonosetron Sales by Region (2018-2023) & (K Units)
Table 40. APAC Palonosetron Sales Market Share by Region (2018-2023)
Table 41. APAC Palonosetron Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Palonosetron Revenue Market Share by Region (2018-2023)
Table 43. APAC Palonosetron Sales by Type (2018-2023) & (K Units)
Table 44. APAC Palonosetron Sales by Application (2018-2023) & (K Units)
Table 45. Europe Palonosetron Sales by Country (2018-2023) & (K Units)
Table 46. Europe Palonosetron Sales Market Share by Country (2018-2023)
Table 47. Europe Palonosetron Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Palonosetron Revenue Market Share by Country (2018-2023)
Table 49. Europe Palonosetron Sales by Type (2018-2023) & (K Units)
Table 50. Europe Palonosetron Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Palonosetron Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Palonosetron Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Palonosetron Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Palonosetron Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Palonosetron Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Palonosetron Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Palonosetron
Table 58. Key Market Challenges & Risks of Palonosetron
Table 59. Key Industry Trends of Palonosetron
Table 60. Palonosetron Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Palonosetron Distributors List
Table 63. Palonosetron Customer List
Table 64. Global Palonosetron Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Palonosetron Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Palonosetron Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Palonosetron Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Palonosetron Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Palonosetron Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Palonosetron Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Palonosetron Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Palonosetron Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Palonosetron Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Palonosetron Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Palonosetron Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Palonosetron Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Palonosetron Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Helsinn Therapeutics Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 79. Helsinn Therapeutics Palonosetron Product Portfolios and Specifications
Table 80. Helsinn Therapeutics Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Helsinn Therapeutics Main Business
Table 82. Helsinn Therapeutics Latest Developments
Table 83. Teva Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Palonosetron Product Portfolios and Specifications
Table 85. Teva Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Teva Main Business
Table 87. Teva Latest Developments
Table 88. Dr. Reddys Laboratories Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 89. Dr. Reddys Laboratories Palonosetron Product Portfolios and Specifications
Table 90. Dr. Reddys Laboratories Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Dr. Reddys Laboratories Main Business
Table 92. Dr. Reddys Laboratories Latest Developments
Table 93. Cipla Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 94. Cipla Palonosetron Product Portfolios and Specifications
Table 95. Cipla Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Cipla Main Business
Table 97. Cipla Latest Developments
Table 98. Pfizer Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Palonosetron Product Portfolios and Specifications
Table 100. Pfizer Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Sandoz Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 104. Sandoz Palonosetron Product Portfolios and Specifications
Table 105. Sandoz Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Sandoz Main Business
Table 107. Sandoz Latest Developments
Table 108. Aurobindo Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 109. Aurobindo Palonosetron Product Portfolios and Specifications
Table 110. Aurobindo Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Aurobindo Main Business
Table 112. Aurobindo Latest Developments
Table 113. Sagent Pharmaceuticals Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 114. Sagent Pharmaceuticals Palonosetron Product Portfolios and Specifications
Table 115. Sagent Pharmaceuticals Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Sagent Pharmaceuticals Main Business
Table 117. Sagent Pharmaceuticals Latest Developments
Table 118. Fresenius Kabi Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 119. Fresenius Kabi Palonosetron Product Portfolios and Specifications
Table 120. Fresenius Kabi Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Fresenius Kabi Main Business
Table 122. Fresenius Kabi Latest Developments
Table 123. Qilu Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 124. Qilu Pharmaceutical Palonosetron Product Portfolios and Specifications
Table 125. Qilu Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Qilu Pharmaceutical Main Business
Table 127. Qilu Pharmaceutical Latest Developments
Table 128. Jiangsu Aosaikang Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 129. Jiangsu Aosaikang Pharmaceutical Palonosetron Product Portfolios and Specifications
Table 130. Jiangsu Aosaikang Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Jiangsu Aosaikang Pharmaceutical Main Business
Table 132. Jiangsu Aosaikang Pharmaceutical Latest Developments
Table 133. Sichuan Hairong Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 134. Sichuan Hairong Pharmaceutical Palonosetron Product Portfolios and Specifications
Table 135. Sichuan Hairong Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 136. Sichuan Hairong Pharmaceutical Main Business
Table 137. Sichuan Hairong Pharmaceutical Latest Developments
Table 138. Exela Pharma Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 139. Exela Pharma Palonosetron Product Portfolios and Specifications
Table 140. Exela Pharma Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 141. Exela Pharma Main Business
Table 142. Exela Pharma Latest Developments
Table 1. Palonosetron Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Palonosetron Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Injection 0.25 mg/5 mL
Table 4. Major Players of Injection 20 mcg/kg (max 1.5 mg)
Table 5. Global Palonosetron Sales by Type (2018-2023) & (K Units)
Table 6. Global Palonosetron Sales Market Share by Type (2018-2023)
Table 7. Global Palonosetron Revenue by Type (2018-2023) & ($ million)
Table 8. Global Palonosetron Revenue Market Share by Type (2018-2023)
Table 9. Global Palonosetron Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Palonosetron Sales by Application (2018-2023) & (K Units)
Table 11. Global Palonosetron Sales Market Share by Application (2018-2023)
Table 12. Global Palonosetron Revenue by Application (2018-2023)
Table 13. Global Palonosetron Revenue Market Share by Application (2018-2023)
Table 14. Global Palonosetron Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Palonosetron Sales by Company (2018-2023) & (K Units)
Table 16. Global Palonosetron Sales Market Share by Company (2018-2023)
Table 17. Global Palonosetron Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Palonosetron Revenue Market Share by Company (2018-2023)
Table 19. Global Palonosetron Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Palonosetron Producing Area Distribution and Sales Area
Table 21. Players Palonosetron Products Offered
Table 22. Palonosetron Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Palonosetron Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Palonosetron Sales Market Share Geographic Region (2018-2023)
Table 27. Global Palonosetron Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Palonosetron Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Palonosetron Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Palonosetron Sales Market Share by Country/Region (2018-2023)
Table 31. Global Palonosetron Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Palonosetron Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Palonosetron Sales by Country (2018-2023) & (K Units)
Table 34. Americas Palonosetron Sales Market Share by Country (2018-2023)
Table 35. Americas Palonosetron Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Palonosetron Revenue Market Share by Country (2018-2023)
Table 37. Americas Palonosetron Sales by Type (2018-2023) & (K Units)
Table 38. Americas Palonosetron Sales by Application (2018-2023) & (K Units)
Table 39. APAC Palonosetron Sales by Region (2018-2023) & (K Units)
Table 40. APAC Palonosetron Sales Market Share by Region (2018-2023)
Table 41. APAC Palonosetron Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Palonosetron Revenue Market Share by Region (2018-2023)
Table 43. APAC Palonosetron Sales by Type (2018-2023) & (K Units)
Table 44. APAC Palonosetron Sales by Application (2018-2023) & (K Units)
Table 45. Europe Palonosetron Sales by Country (2018-2023) & (K Units)
Table 46. Europe Palonosetron Sales Market Share by Country (2018-2023)
Table 47. Europe Palonosetron Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Palonosetron Revenue Market Share by Country (2018-2023)
Table 49. Europe Palonosetron Sales by Type (2018-2023) & (K Units)
Table 50. Europe Palonosetron Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Palonosetron Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Palonosetron Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Palonosetron Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Palonosetron Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Palonosetron Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Palonosetron Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Palonosetron
Table 58. Key Market Challenges & Risks of Palonosetron
Table 59. Key Industry Trends of Palonosetron
Table 60. Palonosetron Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Palonosetron Distributors List
Table 63. Palonosetron Customer List
Table 64. Global Palonosetron Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Palonosetron Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Palonosetron Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Palonosetron Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Palonosetron Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Palonosetron Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Palonosetron Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Palonosetron Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Palonosetron Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Palonosetron Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Palonosetron Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Palonosetron Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Palonosetron Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Palonosetron Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Helsinn Therapeutics Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 79. Helsinn Therapeutics Palonosetron Product Portfolios and Specifications
Table 80. Helsinn Therapeutics Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Helsinn Therapeutics Main Business
Table 82. Helsinn Therapeutics Latest Developments
Table 83. Teva Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Palonosetron Product Portfolios and Specifications
Table 85. Teva Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Teva Main Business
Table 87. Teva Latest Developments
Table 88. Dr. Reddys Laboratories Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 89. Dr. Reddys Laboratories Palonosetron Product Portfolios and Specifications
Table 90. Dr. Reddys Laboratories Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Dr. Reddys Laboratories Main Business
Table 92. Dr. Reddys Laboratories Latest Developments
Table 93. Cipla Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 94. Cipla Palonosetron Product Portfolios and Specifications
Table 95. Cipla Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Cipla Main Business
Table 97. Cipla Latest Developments
Table 98. Pfizer Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Palonosetron Product Portfolios and Specifications
Table 100. Pfizer Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Sandoz Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 104. Sandoz Palonosetron Product Portfolios and Specifications
Table 105. Sandoz Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Sandoz Main Business
Table 107. Sandoz Latest Developments
Table 108. Aurobindo Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 109. Aurobindo Palonosetron Product Portfolios and Specifications
Table 110. Aurobindo Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Aurobindo Main Business
Table 112. Aurobindo Latest Developments
Table 113. Sagent Pharmaceuticals Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 114. Sagent Pharmaceuticals Palonosetron Product Portfolios and Specifications
Table 115. Sagent Pharmaceuticals Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Sagent Pharmaceuticals Main Business
Table 117. Sagent Pharmaceuticals Latest Developments
Table 118. Fresenius Kabi Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 119. Fresenius Kabi Palonosetron Product Portfolios and Specifications
Table 120. Fresenius Kabi Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Fresenius Kabi Main Business
Table 122. Fresenius Kabi Latest Developments
Table 123. Qilu Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 124. Qilu Pharmaceutical Palonosetron Product Portfolios and Specifications
Table 125. Qilu Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Qilu Pharmaceutical Main Business
Table 127. Qilu Pharmaceutical Latest Developments
Table 128. Jiangsu Aosaikang Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 129. Jiangsu Aosaikang Pharmaceutical Palonosetron Product Portfolios and Specifications
Table 130. Jiangsu Aosaikang Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Jiangsu Aosaikang Pharmaceutical Main Business
Table 132. Jiangsu Aosaikang Pharmaceutical Latest Developments
Table 133. Sichuan Hairong Pharmaceutical Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 134. Sichuan Hairong Pharmaceutical Palonosetron Product Portfolios and Specifications
Table 135. Sichuan Hairong Pharmaceutical Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 136. Sichuan Hairong Pharmaceutical Main Business
Table 137. Sichuan Hairong Pharmaceutical Latest Developments
Table 138. Exela Pharma Basic Information, Palonosetron Manufacturing Base, Sales Area and Its Competitors
Table 139. Exela Pharma Palonosetron Product Portfolios and Specifications
Table 140. Exela Pharma Palonosetron Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 141. Exela Pharma Main Business
Table 142. Exela Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Palonosetron
Figure 2. Palonosetron Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Palonosetron Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Palonosetron Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Palonosetron Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Injection 0.25 mg/5 mL
Figure 10. Product Picture of Injection 20 mcg/kg (max 1.5 mg)
Figure 11. Global Palonosetron Sales Market Share by Type in 2022
Figure 12. Global Palonosetron Revenue Market Share by Type (2018-2023)
Figure 13. Palonosetron Consumed in Adults
Figure 14. Global Palonosetron Market: Adults (2018-2023) & (K Units)
Figure 15. Palonosetron Consumed in Children
Figure 16. Global Palonosetron Market: Children (2018-2023) & (K Units)
Figure 17. Global Palonosetron Sales Market Share by Application (2022)
Figure 18. Global Palonosetron Revenue Market Share by Application in 2022
Figure 19. Palonosetron Sales Market by Company in 2022 (K Units)
Figure 20. Global Palonosetron Sales Market Share by Company in 2022
Figure 21. Palonosetron Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Palonosetron Revenue Market Share by Company in 2022
Figure 23. Global Palonosetron Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Palonosetron Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Palonosetron Sales 2018-2023 (K Units)
Figure 26. Americas Palonosetron Revenue 2018-2023 ($ Millions)
Figure 27. APAC Palonosetron Sales 2018-2023 (K Units)
Figure 28. APAC Palonosetron Revenue 2018-2023 ($ Millions)
Figure 29. Europe Palonosetron Sales 2018-2023 (K Units)
Figure 30. Europe Palonosetron Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Palonosetron Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Palonosetron Revenue 2018-2023 ($ Millions)
Figure 33. Americas Palonosetron Sales Market Share by Country in 2022
Figure 34. Americas Palonosetron Revenue Market Share by Country in 2022
Figure 35. Americas Palonosetron Sales Market Share by Type (2018-2023)
Figure 36. Americas Palonosetron Sales Market Share by Application (2018-2023)
Figure 37. United States Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Palonosetron Sales Market Share by Region in 2022
Figure 42. APAC Palonosetron Revenue Market Share by Regions in 2022
Figure 43. APAC Palonosetron Sales Market Share by Type (2018-2023)
Figure 44. APAC Palonosetron Sales Market Share by Application (2018-2023)
Figure 45. China Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Palonosetron Sales Market Share by Country in 2022
Figure 53. Europe Palonosetron Revenue Market Share by Country in 2022
Figure 54. Europe Palonosetron Sales Market Share by Type (2018-2023)
Figure 55. Europe Palonosetron Sales Market Share by Application (2018-2023)
Figure 56. Germany Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Palonosetron Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Palonosetron Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Palonosetron Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Palonosetron Sales Market Share by Application (2018-2023)
Figure 65. Egypt Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Palonosetron in 2022
Figure 71. Manufacturing Process Analysis of Palonosetron
Figure 72. Industry Chain Structure of Palonosetron
Figure 73. Channels of Distribution
Figure 74. Global Palonosetron Sales Market Forecast by Region (2024-2029)
Figure 75. Global Palonosetron Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Palonosetron Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Palonosetron Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Palonosetron Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Palonosetron Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Palonosetron
Figure 2. Palonosetron Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Palonosetron Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Palonosetron Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Palonosetron Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Injection 0.25 mg/5 mL
Figure 10. Product Picture of Injection 20 mcg/kg (max 1.5 mg)
Figure 11. Global Palonosetron Sales Market Share by Type in 2022
Figure 12. Global Palonosetron Revenue Market Share by Type (2018-2023)
Figure 13. Palonosetron Consumed in Adults
Figure 14. Global Palonosetron Market: Adults (2018-2023) & (K Units)
Figure 15. Palonosetron Consumed in Children
Figure 16. Global Palonosetron Market: Children (2018-2023) & (K Units)
Figure 17. Global Palonosetron Sales Market Share by Application (2022)
Figure 18. Global Palonosetron Revenue Market Share by Application in 2022
Figure 19. Palonosetron Sales Market by Company in 2022 (K Units)
Figure 20. Global Palonosetron Sales Market Share by Company in 2022
Figure 21. Palonosetron Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Palonosetron Revenue Market Share by Company in 2022
Figure 23. Global Palonosetron Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Palonosetron Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Palonosetron Sales 2018-2023 (K Units)
Figure 26. Americas Palonosetron Revenue 2018-2023 ($ Millions)
Figure 27. APAC Palonosetron Sales 2018-2023 (K Units)
Figure 28. APAC Palonosetron Revenue 2018-2023 ($ Millions)
Figure 29. Europe Palonosetron Sales 2018-2023 (K Units)
Figure 30. Europe Palonosetron Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Palonosetron Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Palonosetron Revenue 2018-2023 ($ Millions)
Figure 33. Americas Palonosetron Sales Market Share by Country in 2022
Figure 34. Americas Palonosetron Revenue Market Share by Country in 2022
Figure 35. Americas Palonosetron Sales Market Share by Type (2018-2023)
Figure 36. Americas Palonosetron Sales Market Share by Application (2018-2023)
Figure 37. United States Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Palonosetron Sales Market Share by Region in 2022
Figure 42. APAC Palonosetron Revenue Market Share by Regions in 2022
Figure 43. APAC Palonosetron Sales Market Share by Type (2018-2023)
Figure 44. APAC Palonosetron Sales Market Share by Application (2018-2023)
Figure 45. China Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Palonosetron Sales Market Share by Country in 2022
Figure 53. Europe Palonosetron Revenue Market Share by Country in 2022
Figure 54. Europe Palonosetron Sales Market Share by Type (2018-2023)
Figure 55. Europe Palonosetron Sales Market Share by Application (2018-2023)
Figure 56. Germany Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Palonosetron Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Palonosetron Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Palonosetron Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Palonosetron Sales Market Share by Application (2018-2023)
Figure 65. Egypt Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Palonosetron Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Palonosetron in 2022
Figure 71. Manufacturing Process Analysis of Palonosetron
Figure 72. Industry Chain Structure of Palonosetron
Figure 73. Channels of Distribution
Figure 74. Global Palonosetron Sales Market Forecast by Region (2024-2029)
Figure 75. Global Palonosetron Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Palonosetron Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Palonosetron Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Palonosetron Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Palonosetron Revenue Market Share Forecast by Application (2024-2029)
